Rifampicin and clofazimine as multidrug therapy (MDT) for the treatment of Mycobacterium leprae
Dosing
Dermatitis herpetiformis: Start at 50 mg PO daily, increase to 300 mg daily, or higher to achieve full control, reduce to minimum maintenance dosage as soon as possible
PJP prophylaxis (primary or secondary):
100 mg PO once daily or in 2 divided doses as monotherapy
Continue until CD4 count >200 cells/mm3 for >3 months
PJP treatment: 100 mg PO once daily in combination with trimethoprim for 21 days
